Posted by Michael Wonder on 29 Nov 2021
NICE publishes draft guidance on new medicine for osteoporosis
25 November 2021 - The Department of Health and Social Care has asked NICE to produce guidance on using romosozumab in the NHS in England.
Romosozumab is not recommended, within its marketing authorisation, for treating severe osteoporosis after menopause in people at high risk of fracture.
